NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today, Older Adults Technology Services (OATS) from AARP announces an additional $1 million contribution from AT&T to expand access to digital resources for underserved older adults nationwide. The next iteration of work will continue to bring Senior Planet from AARP resources to older adults across the country, subgrant funds to a robust network of licensed partners, and focus on building awareness of the transformative results of the program in conjunction with AT&T's Digital Literacy Connected Learning initiative.

CHICAGO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Sprout Social (Nasdaq: SPT), an industry-leading provider of social media management and analytics software, today launched Sprout AI—the company's most significant intelligence update—anchored by its new proprietary AI Agent, Trellis. Trellis is the conversational agent that leverages Sprout AI to instantly turn billions of unstructured social data points into actionable business answers and transform social media into an enterprise-wide intelligence system.

Yokneam Illit, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (the “Company” or “Wearable Devices”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced that it has successfully implemented and demonstrated a pre-commercial electromyography (“EMG”)-driven weight-estimation capability running on its Mudra Link neural wristband, based on its recently secured patent for weight, torque and force estimation.

NIO continues to report excellent October 2025 deliveries while hinting at outsized FQ4'25 deliveries of 150K units, with it exemplifying the robust natural EV demand. This builds upon its insurance registrations of 10.1K units for the week ending November 02, 2025, along with the robust "figures for the preceding two weeks were 10,500 and 10,300." These numbers are extremely impressive, despite the suspended EV subsidies, the intensifying domestic competition, and the regulators' pivoting EV stance.

New Offer Watch tool lets customers track their vehicle's value over time and choose when to sell New Offer Watch tool lets customers track their vehicle's value over time and choose when to sell

Partnership Focused on Increasing Readership and Engagement, While Opening Additional Revenue Streams Partnership Focused on Increasing Readership and Engagement, While Opening Additional Revenue Streams

Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, EBITDA Accretion and Cashflow Generation Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, EBITDA Accretion and Cashflow Generation

SUNNYVALE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- News Summary Fortinet ® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, and Crime Stoppers International (CSI), the world's only global crime reporting platform, today announced the launch of a global partnership and pioneering Cybercrime Bounty program.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises KBR, Inc., (“KBR” or the "Company") (NYSE: KBR) investors of a class action on behalf of investors that bought securities between May 6, 2025 and June 19, 2025, inclusive (the “Class Period”). KBR investors have until November 18, 2025 to file a lead plaintiff motion.

ATHENS, Greece, Nov. 18, 2025 (GLOBE NEWSWIRE) -- C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the third quarter and nine months ended September 30, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Our handysize dry bulk carriers are on time charters of short-term durations, producing steady cash flows, while our Aframax tanker operates in the spot market, currently achieving voyage charter rates of around $52,000 per day.

PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has adjourned its special meeting of stockholders (the “Special Meeting”) in order to provide stockholders additional time within which to vote on its proposed business combination (the “Business Combination”) with Hyperliquid Strategies Inc (“HSI”) and Rorschach I LLC (“Rorschach”), and the other proposals to be considered at the special meeting.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Alibaba Group Holding Ltd., (“Alibaba” or the “Company”) (NYSE: BABA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

TORONTO, ON / ACCESS Newswire / November 18, 2025 / Wi2Wi Corporation (TSX-V:YTY)(OTC:ISEYF) a leader in precision timing devices, frequency control products, and wireless technologies, today announced its financial results for the third quarter ended September 30, 2025 and leadership transition. Third Quarter Financial Highlights (Reported in $USD) Revenue of $1.75 million, representing a 3% increase compared to $1.71 million in the same period of Fiscal 2024.

HOUSTON, TX / ACCESS Newswire / November 18, 2025 / Via Renewables, Inc. ("Via Renewables" or the "Company") (NASDAQ:VIASP), an independent retail energy services company, announced today that it will redeem 258,565 shares of its 8.75% Series A Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Stock, par value $0.01 per share (the "Series A Preferred Stock" or the "shares"), at a redemption price equal to $25.00 per share in cash, plus $0.46714 per share of accumulated and unpaid dividends thereon (the "Redemption Price") to, but not including, the redemption date of December 18, 2025 (the "Redemption"). All shares of Series A …

HOUSTON, TX, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the publication of an independent, peer-reviewed study in The American Journal on Addictions titled “High-intensity transcranial alternating current stimulation for gambling disorder comorbidities with alcohol use disorders: A case report.” The study evaluated the safety and efficacy of Nexalin's 15 milliamp (mA) neurostimulation device in a patient diagnosed with both gambling disorder (GD) and alcohol use disorder (AUD).

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises RCI Hospitality Holdings, Inc., (“RICK” or the "Company") (NYSE: RICK) investors of a class action on behalf of investors that bought securities between December 15, 2021 and September 16, 2025, inclusive (the “Class Period”). RCI investors have until November 20, 2025 to file a lead plaintiff motion.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Quanex Building Products Corporation, (“Quanex” or the “Company”) (NYSE: NX) investors of a class action on behalf of investors that bought securities between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”). Quanex investors have until November 18, 2025 to file a lead plaintiff motion.

Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region PLEASANTON, Calif. and SYDNEY , Nov. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc.

SALT LAKE CITY , Nov. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has begun clinical evaluations for its Co-Dx™ PCR Flu A/B, COVID-19, RSV Test Kit. The clinical performance testing is expected to support a submission to the United States Food and Drug Administration ("FDA") for 510(k) clearance of the upper respiratory multiplex point-of-care test, and the Co-Dx PCR Pro™* instrument.